14.16
-0.15(-1.05%)
Currency In USD
Address
21 Hickory Drive Suite 500
Waltham, MA 02451
United States of America
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
41
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Mr. Michael Cloonan M.B.A. | President, Chief Executive Officer & Director | 784,593 | 1972 |
| Ms. Elena H. Ridloff C.F.A. | Chief Financial Officer & Head of Corporate Development | 647,922 | 1980 |
| Dr. Charlotte McKee M.D. | Chief Medical Officer | 647,922 | 1965 |
| Ms. Mara Furlow M.S. | Senior Vice President of Global Regulatory Affairs & Quality | 0 | N/A |
| Dr. Greg Hurlbut Ph.D. | Co-Founder & Senior Vice President of Discovery Research | 0 | N/A |
| Ms. Vanya Sagar | Chief People Officer | 0 | 1976 |
| Ms. Jennifer Fitzpatrick J.D. | Chief Legal Officer | 0 | 1977 |
| Mr. Andy Chu | Vice President of Information & Technology | 0 | N/A |
| Dr. Mark Munson Ph.D. | Co-founder & Senior Vice President of Medicinal Chemistry | 0 | N/A |
| Ms. Meghan Bagshaw | Vice President of Programs, Portfolio & Operations | 0 | N/A |
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.